Laxative use and chronic diarrhoea in older adults living in residential care
Leigh O'Brien1, Catherine Wall1, Tim J Wilkinson1
1Department of Medicine, University of Otago, Christchurch, New Zealand.
Aims:
Chronic diarrhoea in older adults in residential care is underreported. This study examined its prevalence, contributing factors, and impacts on the quality of life of older adults living in care throughout New Zealand.
Methods:
This study had two components: (1) a retrospective observational study of resident clinical, medication, bowel chart and health care data from 36 residential care facilities electronically entered by nursing or care staff, and (2) an observational study in six facilities where residents completed validated gastrointestinal and quality of life questionnaires. Residents were categorised by bowel pattern (normal, constipation, and diarrhoea) using Rome IV criteria. Chi-square tests compared bowel patterns with quality of life outcomes. Associations between bowel symptom reporting in parts one and two were assessed using contingency tables.
Results:
The retrospective data of 2411 residents revealed that 26% (618/2411) experienced chronic diarrhoea, most of whom were taking laxatives (402/618), presumably for constipation. The prevalence of chronic diarrhoea in non-laxative users was 8.8% (214/2411). Proportions were similar in part two: 21% (23/110) of residents experienced chronic diarrhoea, half of whom were also charted laxatives (12/23). Chronic diarrhoea was negatively associated with quality of life (p < 0.001) and associated with an increased risk of pressure injuries (n = 80, 12.9%) compared to having normal bowel motions (n = 20, 7%) (p < 0.001).
Conclusions:
Chronic diarrhoea commonly affects older adults living in residential care, with laxative use appearing a significant contributor. Living with chronic diarrhoea can negatively impact quality of life and may be associated with an increased risk of pressure injury.
Related Concept Videos
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Constipation-Predominant IBS


